BRAF and metastatic malignant neoplasm in the lymph nodes: Our results suggest that beyond BRAF V600E AF, genetic variability, age and ethnicity may contribute to the heterogenous rate of carcinogenic cell proliferation, tumor growth, and subsequent lymph node metastasis [30,32].